Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label multicenter access protocol of Pegasys with or without Copegus in chronic hepatitis C patients from prior Roche trials
2008-002022-10Phase 3Completed
- Sponsor
- Roche
- Start
- Jun 2008
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of interferon alfa and ribavirin in hepatitis C virus infection (2 arms), sponsored by Roche. Started Jun 2008; status: completed.
02
Drugs
interferon alfaribavirin
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2008-002022-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002022-10.